miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-24
DOI
10.1038/s41419-019-1715-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma
- (2019) E. V. Koldysheva et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma
- (2018) Fangfang Tao et al. FASEB JOURNAL
- miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
- (2018) Xiaomin Meng et al. OncoTargets and Therapy
- LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling
- (2018) Shanyi Zhang et al. Cell Death & Disease
- Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy
- (2018) Anastasia O. Komarova et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models
- (2018) A.L. Zakharenko et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Epidemiology and treatment patterns of epithelial ovarian cancer
- (2017) Philip Jessmon et al. Expert Review of Anticancer Therapy
- The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer
- (2017) Xuerui Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma
- (2017) Jun Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- The expression of miRNAs is associated with tumour genome instability and predicts the outcome of ovarian cancer patients treated with platinum agents
- (2017) Tianzhen Wang et al. Scientific Reports
- Current status on microRNAs as biomarkers for ovarian cancer
- (2016) Kira Philipsen Prahm et al. APMIS
- miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
- (2015) Bairong Xia et al. Molecular Cancer
- Lin28A enhances chemosensitivity of colon cancer cells to 5-FU by promoting apoptosis in a let-7 independent manner
- (2015) Tianzhen Wang et al. TUMOR BIOLOGY
- Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
- (2015) Dimitra T. Stefanou et al. PLoS One
- Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity
- (2015) Swapna Asuthkar et al. Oncotarget
- Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)
- (2014) Yves Pommier et al. DNA REPAIR
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Clinical and Cellular Roles for TDP1 and TOP1 in Modulating Colorectal Cancer Response to Irinotecan
- (2014) C. Meisenberg et al. MOLECULAR CANCER THERAPEUTICS
- RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development
- (2013) W.-j. Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Role for Small RNAs in DNA Double-Strand Break Repair
- (2012) Wei Wei et al. CELL
- MicroRNAs and DNA damage response
- (2012) Yemin Wang et al. CELL CYCLE
- A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy
- (2012) Josephine Kang et al. JNCI-Journal of the National Cancer Institute
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy
- (2012) E. M. McNeil et al. NUCLEIC ACIDS RESEARCH
- The ATM Kinase Induces MicroRNA Biogenesis in the DNA Damage Response
- (2011) Xinna Zhang et al. MOLECULAR CELL
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
- (2010) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
- (2010) Bryan T.J. Hennessy et al. JOURNAL OF CLINICAL ONCOLOGY
- ATM is down-regulated by N-Myc-regulated microRNA-421
- (2010) H. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search